(a) Performance characteristics of biochemical markers for predicting early AKI development (n =66) | ||||||
---|---|---|---|---|---|---|
Time from admission | ||||||
0 h | 3 h | 6 h | 12 h | 24 h | 48 h | |
AUC of serum creatinine | 0.816* | 0.823* | 0.881* | 0.988* | 0.987* | 0.898* |
Cut-off value, mg/dL | 0.85 | 0.85 | 0.85 | 1.05 | 1.15 | 0.95 |
Sensitivity | 0.710 | 0.645 | 0.700 | 0.926 | 0.913 | 0.778 |
Specificity | 0.706 | 0743 | 0.824 | 0.971 | 1.000 | 0.853 |
AUC of serum cystatin C | 0.615 | 0.54 | 0.605 | 0.746* | 0.731* | 0.619 |
Cut-off value, mg/L | 0.70 | 0.75 | ||||
Sensitivity | 0.704 | 0.652 | ||||
Specificity | 0.500 | 0.618 | ||||
AUC of plasma NGAL | 0.832* | 0.905* | 0.926* | 0.847* | 0.818* | 0.705* |
Cut-off value, ng/mL | 100.5 | 172.0 | 159.0 | 175.5 | 185.5 | 144.0 |
Sensitivity | 0.806 | 0.806 | 0.900 | 0.815 | 0.739 | 0.667 |
Specificity | 0.735 | 0.800 | 0.794 | 0.765 | 0.912 | 0.647 |
AUC of urine NGAL | 0.921* | 0.927* | 0.896* | 0.813* | 0.914* | 0.802* |
Cut-off value, ng/mL | 36.6 | 31.9 | 26.8 | 26.8 | 42.3 | 52.9 |
Sensitivity | 0.871 | 0.871 | 0.800 | 0.815 | 0.870 | 0.722 |
Specificity | 0.824 | 0.829 | 0.853 | 0.765 | 0.824 | 0.706 |
(b) Performance characteristics of biochemical markers for predicting late AKI development (n = 59) | ||||||
Time from admission | ||||||
0 h | 3 h | 6 h | 12 h | 24 h | 48 h | |
AUC of serum creatinine | 0.581 | 0.55 | 0.609 | 0.605 | 0.660* | 0.625 |
Cut-off value, mg/dL | 0.85 | |||||
Sensitivity | 0.739 | |||||
Specificity | 0.676 | |||||
AUC of serum cystatin C | 0.488 | 0.437 | 0.545 | 0.491 | 0.513 | 0.444 |
AUC of plasma NGAL | 0.682* | 0.658* | 0.670* | 0.605 | 0.571 | 0.537 |
Cut-off value, ng/mL | 102.5 | 100.0 | 125.0 | |||
Sensitivity | 0.640 | 0.583 | 0.625 | |||
Specificity | 0.735 | 0.629 | 0.676 | |||
AUC of urine NGAL | 0.692* | 0.681* | 0.644 | 0.599 | 0.598 | 0.604 |
Cut-off value, ng/mL | 11.95 | 7.25 | 8.25 | |||
Sensitivity | 0.680 | 0.708 | 0.625 | |||
Specificity | 0.647 | 0.600 | 0.588 |